Immediate Impact
2 from Science/Nature 103 standout
Citing Papers
Oesophageal cancer
2024 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
Works of D.B. Shin being referenced
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
2015
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| D.B. Shin | 390 | 591 | 263 | 266 | 17 | 685 | |
| Dmitry Bichev | 312 | 611 | 340 | 238 | 15 | 660 | |
| M. Wenczl | 416 | 548 | 197 | 114 | 15 | 690 | |
| V. Mutri | 422 | 416 | 187 | 117 | 22 | 610 | |
| Nadine Röthling | 310 | 486 | 397 | 81 | 11 | 645 | |
| Alberto Di Leo | 108 | 545 | 285 | 273 | 16 | 629 | |
| G Mori | 113 | 508 | 349 | 235 | 12 | 585 | |
| Sunao Moriguchi | 151 | 434 | 326 | 133 | 17 | 635 | |
| Junichiro Nasu | 342 | 586 | 301 | 324 | 26 | 768 | |
| S. Giaquinta | 477 | 455 | 214 | 117 | 24 | 658 | |
| Pamela Dumas | 245 | 503 | 254 | 243 | 13 | 670 |
All Works
Loading papers...